Original ArticleApplication of planar chromatography for estimation of Lercanidipine hydrochloride (cas 132866-11-6) in dosage form
-
Add time:08/25/2019 Source:sciencedirect.com
A new simple, precise, accurate, and selective high performance thin-layer chromatographic (HPTLC) method has been developed for analysis of Lercanidipine hydrochloride (cas 132866-11-6) (LER) in a tablet, using chloroform:toluene:methanol:acetic acid (8:1:1:1; v/v/v/v) as mobile phase. Chromatographic separation was achieved on precoated silica gel 60F254 plates with 0.2 mm thickness. Detection was performed densitometrically using a UV detector at 365 nm. The retention factor of lercanidipine hydrochloride was RF 0.55 (±0.02). The reliability of the method was assessed by evaluation of linearity 30–210 ng per band. The suitability of this HPTLC method for quantitative determination of LER was proved by validation in accordance with the requirement of pharmaceutical regulatory standards. The method was found to be reproducible and convenient for determination of compound in commercial pharmaceutical formulations. The advantage of the method is simplicity, reasonable sensitivity, rapidity, excellent resolving power, low cost and is a more effective option than other chromatographic techniques in routine quality control.
We also recommend Trading Suppliers and Manufacturers of Lercanidipine hydrochloride (cas 132866-11-6). Pls Click Website Link as below: cas 132866-11-6 suppliers
Prev:Development of a fractionation method for the detection and identification of oak ellagitannins in red wines
Next:Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of Lercanidipine hydrochloride (cas 132866-11-6)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- A novel nanoproliposomes of lercanidipine: Development, in vitro and preclinical studies to support its effectiveness in hypertension therapy09/02/2019
- Research paperDevelopment of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation09/01/2019
- Original ArticleDetermination of lercanidipine in human plasma by an improved UPLC–MS/MS method for a bioequivalence study☆08/31/2019
- Invited paperSubstituent effect of side chains on the photochemical behavior of a new generation 1,4-dihydropyridine: Lercanidipine08/30/2019
- pH-0064ependent gradient release microspheres of Lercanidipine hydrochloride (cas 132866-11-6): in vitro and in vivo evaluation08/29/2019
- Oral self emulsifying powder of Lercanidipine hydrochloride (cas 132866-11-6): Formulation and evaluation08/28/2019
- Research paperSolid self-emulsified nanostructures of Lercanidipine hydrochloride (cas 132866-11-6): A potential approach to improve the fraction of the dose absorbed08/27/2019
- Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of Lercanidipine hydrochloride (cas 132866-11-6)08/26/2019
-
Health and Chemical more >


